MERCK & CO.: REPORT CLEARS TOP MANAGEMENT IN DEVELOPMENT, SALES OF VIOXX

Merck & Co.'s board of directors said Wednesday that a 20-month investigation funded by the company found that senior management acted responsibly in its development and marketing of its now-withdrawn pain reliever Vioxx. Chicago Tribune (http://www.chicagotribune.com/business/chi-0609070205sep07,1,718293.story?coll=chi-business-hed)